Stablix Therapeutics

Last updated: May 05, 2024

Clare Ozawa, CEO
Clare Ozawa, CEO
Country: USA | Funding: $63M (+)

Website: https://www.stablix.com/

Stablix Therapeutics, a biotechnology company pioneering the Targeted Protein Stabilization technologies that is used to cure cystic fibrosis and cancer